Ticker
FATECompany Name
FATE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Core Assets | Goodwill and Intangibles |
---|---|---|---|---|
6/30/2025 | $ 371.63M | $ 51.48M | $ 320.16M | $ 0 |
3/31/2025 | $ 398.67M | $ 55.15M | $ 343.52M | $ 0 |
12/31/2024 | $ 440.69M | $ 46.28M | $ 394.41M | $ 0 |
9/30/2024 | $ 494.97M | $ 48.14M | $ 446.83M | $ 0 |
6/30/2024 | $ 528.82M | $ 52.09M | $ 476.72M | $ 0 |
3/31/2024 | $ 569.89M | $ 136.5M | $ 433.39M | $ 0 |
12/31/2023 | $ 506.22M | $ 57.05M | $ 449.17M | $ 0 |
9/30/2023 | $ 543.79M | $ 48.51M | $ 495.28M | $ 0 |
6/30/2023 | $ 584.76M | $ 61.98M | $ 522.78M | $ 0 |
3/31/2023 | $ 630.34M | $ 57.25M | $ 573.09M | $ 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Assets - Intangibles - CashnEq
(=) Core Assets
Core Assets for FATE THERAPEUTICS INC is calculated as follows: Assets [ $ 626.44M ] - Intangibles [ $ 0 ] - CashnEq [ $ 364.36M ]
(=) Core Assets [ $ 262.09M ]
Minimum
Sep 30, 2020
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.42K |
---|---|
min | $ 0 |
max | $ 4.38B |
average | $ 799.74M |
median | $ 287.51M |
std | $ 1.05B |